# SPNS1

## Overview
SPNS1 is a gene that encodes the SPNS lysolipid transporter 1, a transmembrane protein primarily involved in the transport of lysosphingolipids and lysoglycerophospholipids from lysosomes. This protein plays a critical role in maintaining lysosomal homeostasis and lipid recycling, which are essential for cellular function and organismal development (Ichimura2024Loss; Ha2022SPNS1). The SPNS1 protein is localized in late endosomes and lysosomes, where it facilitates the release of sphingosines, contributing to the formation of sphingosine-1-phosphate and ceramides in the cytoplasm (Ha2022SPNS1). These processes are vital for lipid recycling and the maintenance of autophagic lysosomal homeostasis, which is crucial for cellular waste degradation and recycling (Sasaki2014Aberrant). Deficiencies or mutations in SPNS1 have been linked to various pathological conditions, including lysosomal storage diseases and neurodegenerative disorders, highlighting its significance in human health (Ichimura2024Loss; Ha2022SPNS1).

## Function
SPNS1 is a gene that encodes a protein involved in the transport of lysosphingolipids and lysoglycerophospholipids from lysosomes, playing a crucial role in maintaining lysosomal homeostasis and lipid recycling in healthy human cells (Ichimura2024Loss; Ha2022SPNS1). The SPNS1 protein is primarily localized in late endosomes and lysosomes, where it facilitates the release of sphingosines, which are then converted into sphingosine-1-phosphate (S1P) and ceramides in the cytoplasm (Ha2022SPNS1). This process is essential for the recycling of lipids within lysosomes and their subsequent re-esterification into phosphatidylcholine in the cytosol (Ichimura2024Loss).

SPNS1 is also implicated in the regulation of autophagic lysosomal homeostasis. It is involved in the formation of autolysosomes, which are crucial for cellular waste degradation and recycling processes (Sasaki2014Aberrant). The protein's role in lysosomal acidification and trafficking is vital for proper autophagic function, ensuring the degradation of autophagic cargos by maintaining the acidic environment necessary for the activity of hydrolytic enzymes (Yanagisawa2017Lleucine; Sasaki2014Aberrant). These functions are critical for cellular homeostasis and organismal development, as evidenced by the embryonic lethality observed in SPNS1-deficient models (Ha2022SPNS1).

## Clinical Significance
Mutations or deficiencies in the SPNS1 gene have been linked to several pathological conditions, particularly those resembling lysosomal storage diseases (LSDs). SPNS1 is crucial for the transport of lysosphingolipids and lysoglycerophospholipids from lysosomes, and its deficiency leads to the accumulation of these lipids, resulting in conditions similar to sphingolipid LSDs such as Gaucher, Sandhoff, Fabry, Tay-Sachs, and Niemann-Pick type C diseases (Ha2022SPNS1). In mice, global knockout of SPNS1 results in embryonic lethality, while postnatal deletion causes lipid accumulation in lysosomes, leading to phenotypes reminiscent of LSDs, including foamy hepatocytes and liver hyperplasia (Ha2022SPNS1).

In the nervous system, SPNS1 deficiency is associated with neurodegenerative conditions. Nervous system-specific knockout mice exhibit symptoms such as epilepsy, growth retardation, and early death, with dysmyelination and white matter dysplasia due to the accumulation of lysophospholipids and sphingosine in the brain (Ichimura2024Loss). These findings suggest that SPNS1 mutations may contribute to congenital cerebral white matter dysplasia and other neurological conditions (Ichimura2024Loss). Additionally, SPNS1 mutations in zebrafish lead to cardiac defects, indicating its role in cardiac valve development (Chávez2024Spns1dependent).


## References


1. (Chávez2024Spns1dependent) Spns1-dependent endocardial lysosomal function drives valve morphogenesis through Notch1-signaling. This article has 0 citations.

[2. (Yanagisawa2017Lleucine) Hiroko Yanagisawa, Tomohiro Ishii, Kentaro Endo, Emiko Kawakami, Kazuaki Nagao, Toshiyuki Miyashita, Keiko Akiyama, Kazuhiko Watabe, Masaaki Komatsu, Daisuke Yamamoto, and Yoshikatsu Eto. L-leucine and spns1 coordinately ameliorate dysfunction of autophagy in mouse and human niemann-pick type c disease. Scientific Reports, November 2017. URL: http://dx.doi.org/10.1038/s41598-017-15305-9, doi:10.1038/s41598-017-15305-9. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-15305-9)

3. (Ichimura2024Loss) Loss of SPNS1, a lysosomal transporter, in the nervous system causes dysmyelination and white matter dysplasia. This article has 0 citations.

4. (Ha2022SPNS1) SPNS1 is required for the transport of lysosphingolipids and lysoglycerophospholipids from lysosomes. This article has 1 citations.

[5. (Sasaki2014Aberrant) Tomoyuki Sasaki, Shanshan Lian, Jie Qi, Peter E. Bayliss, Christopher E. Carr, Jennifer L. Johnson, Sujay Guha, Patrick Kobler, Sergio D. Catz, Matthew Gill, Kailiang Jia, Daniel J. Klionsky, and Shuji Kishi. Aberrant autolysosomal regulation is linked to the induction of embryonic senescence: differential roles of beclin 1 and p53 in vertebrate spns1 deficiency. PLoS Genetics, 10(6):e1004409, June 2014. URL: http://dx.doi.org/10.1371/journal.pgen.1004409, doi:10.1371/journal.pgen.1004409. This article has 48 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1004409)